CSIMarket Company Name, Ticker, Customers, else..


Xoma Royalty Corporation  (NASDAQ: XOMA)
Other Ticker:  
 

Xoma Royalty Corporation

XOMA's Fundamental analysis



Looking into Xoma Royalty growth rates, revenue grew by 967.92 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 25

Major Pharmaceutical Preparations industry recorded growth of revenues by 4.43 %

Xoma Royalty realized net income compared to net loss a year ago in first quarter of 2025

• More on XOMA's Growth


Xoma Royalty
realized a net loss in trailing twelve months.

Xoma Royalty realized cash reduction of $ -2.66 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 10.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.


• More on XOMA's Valuation
 
 Total Debt (Millions $) 114
 Dividend TTM ($) 0.27 $
 Dividend Yield TTM (%) 0.81 %
 Revenue/Employee (TTM) $ 3,300,692
 Net Income/Employee (TTM) $ -768,692
 Receivable Turnover (TTM) 19.17
 Tangible Book Value (Per Share $) 3.33

Xoma Royalty
realized net loss in trailing twelve months.

Xoma Royalty realized cash outflow of $ -2.66per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 10.2.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.32.

Xoma Royalty Price to Book Ratio is at 5.17 lower than Industry Avg. of 34.08. and higher than S&P 500 Avg. of 0.01

• More on XOMA's Valuation

•  Market Capitalization (Millions $) 438
•  Shares Outstanding (Millions) 18
•  Employees 13
•  Revenues (TTM) (Millions $) 43
•  Net Income (TTM) (Millions $) -10
•  Cash Flow (TTM) (Millions $) -47
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) 114
•  Dividend TTM ($) 0.27 $
•  Dividend Yield TTM (%) 0.81 %
•  Revenue/Employee (TTM) $ 3,300,692
•  Net Income/Employee(TTM) $ -768,692
•  Receivable Turnover Ratio (TTM) 19.17
•  Tangible Book Value (Per Share $) 3.33

•  Market Capitalization (Millions $) 438
•  Shares Outstanding (Millions) 18
•  Employees 13
•  Revenues (TTM) (Millions $) 43
•  Net Income (TTM) (Millions $) -10
•  Cash Flow (TTM) (Millions $) -47
•  Capital Exp. (TTM) (Millions $) -


    XOMA's Profitability Comparisons
Xoma Royalty achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 37.26 %.

Xoma Royalty net profit margin of 4.43 % is currently ranking no. 51 in Major Pharmaceutical Preparations industry, ranking no. 144 in Healthcare sector and number 1703 in S&P 500.


Profitability by Segment
Total 4.43 %



  Ratio
•   Capital Ratio (MRQ) 5.54
•  Total Debt to Equity (MRQ) 1.34
•  Tangible Leverage Ratio (MRQ) 2.16
•  Asset Turnover Ratio (TTM) 0.19
•  Inventory Turnover Ratio (TTM) -



Xoma Royalty achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in first quarter of 2025 to 37.26 %.

Xoma Royalty net profit margin of 4.43 % is currently ranking no. 51 in Major Pharmaceutical Preparations industry, ranking no. 144 in Healthcare sector and number 1703 in S&P 500.

• More on XOMA's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com